Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126816292 | 12681629 | 2 | F | 201607 | 20160909 | 20160824 | 20160916 | EXP | IT-GILEAD-2016-0229714 | GILEAD | 44.00 | YR | A | M | Y | 60.00000 | KG | 20160916 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126816292 | 12681629 | 1 | PS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | UNK | Y | 21752 | TABLET | ||||||||
| 126816292 | 12681629 | 2 | C | ATAZANAVIR W/RITONAVIR | ATAZANAVIRRITONAVIR | 1 | 0 | ||||||||||||
| 126816292 | 12681629 | 3 | C | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK | 0 | |||||||||||
| 126816292 | 12681629 | 4 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 126816292 | 12681629 | 5 | C | CEFTRIAXONE. | CEFTRIAXONE | 1 | 2 G, UNK | 0 | 2 | G | |||||||||
| 126816292 | 12681629 | 6 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 126816292 | 12681629 | 7 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 8 MG, UNK | 0 | 8 | MG | |||||||||
| 126816292 | 12681629 | 8 | C | ANTRA /00661201/ | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 126816292 | 12681629 | 9 | C | SOLDESAM | DEXAMETHASONE | 1 | 12 MG, UNK | 0 | 12 | MG | |||||||||
| 126816292 | 12681629 | 10 | C | BLEOMYCIN | BLEOMYCIN SULFATE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126816292 | 12681629 | 11 | C | VINBLASTINE | VINBLASTINE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126816292 | 12681629 | 12 | C | DACARBAZINE. | DACARBAZINE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126816292 | 12681629 | 13 | C | DOXORUBICIN HYDROCHLORIDE INJECTION | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126816292 | 12681629 | 1 | Product used for unknown indication |
| 126816292 | 12681629 | 3 | Antifungal prophylaxis |
| 126816292 | 12681629 | 4 | Oral candidiasis |
| 126816292 | 12681629 | 5 | Pneumonia |
| 126816292 | 12681629 | 6 | Pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126816292 | 12681629 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126816292 | 12681629 | Albuminuria | |
| 126816292 | 12681629 | Blood creatinine increased | |
| 126816292 | 12681629 | Blood phosphorus abnormal | |
| 126816292 | 12681629 | Hodgkin's disease | |
| 126816292 | 12681629 | Urine analysis abnormal | |
| 126816292 | 12681629 | Urine phosphorus abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126816292 | 12681629 | 1 | 20160723 | 0 | ||
| 126816292 | 12681629 | 3 | 20160809 | 0 | ||
| 126816292 | 12681629 | 4 | 20160809 | 0 | ||
| 126816292 | 12681629 | 5 | 20150712 | 0 | ||
| 126816292 | 12681629 | 6 | 20160812 | 0 | ||
| 126816292 | 12681629 | 10 | 20160824 | 0 | ||
| 126816292 | 12681629 | 11 | 20160824 | 0 | ||
| 126816292 | 12681629 | 12 | 20160824 | 0 |